1. U.S. Food and Drug Administration.FDA approves first interchangeable biosimilar insulin product for treatment of diabetes(2021).
2. Insulins: Past, Present, and Future
3. U.S. Food and Drug Administration.Interpretation of the "deemed to be a licence" provision of the biologics price competition and innovation act of 2009. Guidance for Industry(2018).
4. U.S. Food and Drug Administration.Scientific Considerations in Demonstrating Biosimilarity to a Reference Product(2015).
5. U.S. Food and Drug Administration.Considerations in demonstrating interchangeability with a reference product: Guidance for industry(2019).